|Santen Pharmaceutical Co Ltd -- USA Stock|| |
USD 16.58 0.21 1.25%
CIO, Head of Information Systems Division and Corporate Officer
We currently do not have informatin regarding Noriaki Yamamoto. This executive tanure with Santen Pharmaceutical Co Ltd is not currenlty determined.
81 6 6321 7000 http://www.santen.com
The company has return on total asset (ROA)
of 6.34 %
which means that it generated profit of $6.34 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 11.43 %
meaning that it generated $11.43 on every $100 dollars invested by stockholders.
Santen Pharmaceutical Co., Ltd., together with its subsidiaries, researches and develops, produces, and markets prescription ophthalmic pharmaceutical products for the protection and enhancement of eyesight and health primarily in Japan. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan. Santen Pharmaceutical is traded on OTC Market in USA.Santen Pharmaceutical Co Ltd (SNPHY) is traded on OTC Market in USA. It is located in Grand Front Osaka Tower A and employs 3,667 people.